Harnessing Real-World Data and Evidence to Accelerate Drug Development

Discover ways that RWE accelerates development, de-risks decisions and unlocks real-world success.

Real-world data (RWD) and real-world evidence (RWE) are redefining how drugs are developed, evaluated and commercialized. As regulatory expectations rise and competition intensifies, biotech and pharmaceutical teams need evidence that goes beyond clinical trials to support smarter decisions, faster timelines and stronger differentiation.

This interactive playbook explores how strategically applied RWE helps answer critical questions across the asset lifecycle—from early development through commercialization and post-marketing—to generate fit-for-purpose evidence that meets the needs of regulators, payers, clinicians and patients.

In this playbook, you’ll learn how to:

Use RWE to understand disease burden, patient populations and unmet medical needs.

Build a fit-for-purpose RWD strategy aligned to your asset and stage.

Optimize trial design, feasibility and patient recruitment.

Strengthen market access, reimbursement and value demonstration.

Proactively plan for post-approval safety and regulatory commitments.

Align evidence generation across stakeholders, with confidence.

Discover ways that RWE accelerates development, de-risks decisions and unlocks real-world success. Download the playbook.

Accelerate development, de-risk decisions and unlock real-world success.

Access the playbook by completing the form below.